Dennemeyer Consulting conducted a holistic study over the summer of 2018 to assist Bavaria's Ministry of Economic Affairs in its plans to optimize Bavaria’s support infrastructure for SME and start-up patenting activities.
The European Patent Office (EPO) announced that it had reached its quota for the Collaborative Search and Examination pilot project after only two months and a half from launch. Here are the first promising results.
Dr. Christopher Brückner joins the international IP law firm Dennemeyer & Associates in Munich. He is a specialist in Supplementary Protection Certificates (SPCs) and the author of the only relevant commentary literature about SPCs.
Dennemeyer & Associates' Frosecution™ solution is a creative approach to patent preparations. In this article featured in WIPR - World IP Review, Steven Shape, Dr. Malte Köllner & Cary Levitt explain how one Dennemeyer office takes responsibility for the entire lifecycle of international patent applications, including filing and prosecution through to grant.
The first IP Trend Monitor study, which focused on the impact of digitalization on the management of IP, has been finalized.
40 years ago, Chapter I of the Patent Cooperation Treaty (PCT) entered into force. The PCT initially applied in 13 States. In 2017, Jordan became the 152nd state to join the system.
Dr. Anthony Carlick, European Patent Attorney at Dennemeyer & Associates, discusses the Unified Patent Court Agreement (UPC) in light of Brexit and attempts to make some predictions.
Artificial intelligence always sounds easy but, in reality, big data analysis with artificial intelligence is a lot of work. Oliver Mayer, Senior Principal at General Electric - Global Research, puts the spotlight on big data and talks about patterns in patents.
For a UKIPO validity opinion, only newly raised grounds will be analyzed, but these can include insufficiency and added matter arguments, as well as arguments based on novelty and / or inventive step.
The Dennemeyer Group consolidates its global management team with Dr. Dallas Wilkinson who will lead the offices in Australia, Japan, China and Singapore thus driving Dennemeyer's further regional expansion planned for the next years across the Asia Pacific region.